Rights and permissions
About this article
Cite this article
Temozolomide is an active agent for the treatment of primary brain lymphomas. Nat Rev Clin Oncol 4, 390–391 (2007). https://doi.org/10.1038/ncponc0841
Issue Date:
DOI: https://doi.org/10.1038/ncponc0841
- Springer Nature Limited